FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892271400> ?p ?o ?g. }

• W2892271400 endingPage "k3426" @default.
• W2892271400 startingPage "k3426" @default.
• W2892271400 abstract "To examine the cardiovascular risks of diclofenac initiation compared with initiation of other traditional non-steroidal anti-inflammatory drugs, initiation of paracetamol, and no initiation.Series of 252 nationwide cohort studies, each mimicking the strict design criteria of a clinical trial (emulated trial design).Danish, nationwide, population based health registries (1996-2016).Individuals eligible for inclusion were all adults without malignancy; schizophrenia; dementia; or cardiovascular, kidney, liver, or ulcer diseases (that is, with low baseline risk). The study included 1 370 832 diclofenac initiators, 3 878 454 ibuprofen initiators, 291 490 naproxen initiators, 764 781 healthcare seeking paracetamol initiators matched by propensity score, and 1 303 209 healthcare seeking non-initiators also matched by propensity score.Cox proportional hazards regression was used to compute the intention to treat hazard ratio (as a measure of the incidence rate ratio) of major adverse cardiovascular events within 30 days of initiation.The adverse event rate among diclofenac initiators increased by 50% compared with non-initiators (incidence rate ratio 1.5, 95% confidence interval 1.4 to 1.7), 20% compared with paracetamol or ibuprofen initiators (both 1.2, 1.1 to 1.3), and 30% compared with naproxen initiators (1.3, 1.1 to 1.5). The event rate for diclofenac initiators increased for each component of the combined endpoint (1.2 (1.1 to 1.4) for atrial fibrillation/flutter, 1.6 (1.3 to 2.0) for ischaemic stroke, 1.7 (1.4 to 2.0) for heart failure, 1.9 (1.6 to 2.2) for myocardial infarction, and 1.7 (1.4 to 2.1) for cardiac death) as well as for low doses of diclofenac, compared with non-initiators. Although the relative risk of major adverse cardiovascular events was highest in individuals with low or moderate baseline risk (that is, diabetes mellitus), the absolute risk was highest in individuals with high baseline risk (that is, previous myocardial infarction or heart failure). Diclofenac initiation also increased the risk of upper gastrointestinal bleeding at 30 days, by approximately 4.5-fold compared with no initiation, 2.5-fold compared with initiation of ibuprofen or paracetamol, and to a similar extent as naproxen initiation.Diclofenac poses a cardiovascular health risk compared with non-use, paracetamol use, and use of other traditional non-steroidal anti-inflammatory drugs." @default.
• W2892271400 created "2018-09-27" @default.
• W2892271400 creator A5006148147 @default.
• W2892271400 creator A5050587534 @default.
• W2892271400 creator A5067129696 @default.
• W2892271400 date "2018-09-04" @default.
• W2892271400 modified "2023-10-14" @default.
• W2892271400 title "Diclofenac use and cardiovascular risks: series of nationwide cohort studies" @default.
• W2892271400 cites W1599185368 @default.
• W2892271400 cites W1780627874 @default.
• W2892271400 cites W1975731142 @default.
• W2892271400 cites W1978136073 @default.
• W2892271400 cites W1978670003 @default.
• W2892271400 cites W1990165855 @default.
• W2892271400 cites W1993961357 @default.
• W2892271400 cites W2001162433 @default.
• W2892271400 cites W2004140440 @default.
• W2892271400 cites W2010818945 @default.
• W2892271400 cites W2030235211 @default.
• W2892271400 cites W2037404308 @default.
• W2892271400 cites W2042559969 @default.
• W2892271400 cites W2043956359 @default.
• W2892271400 cites W2055394727 @default.
• W2892271400 cites W2055691692 @default.
• W2892271400 cites W2067443499 @default.
• W2892271400 cites W2082081076 @default.
• W2892271400 cites W2084824705 @default.
• W2892271400 cites W2086928528 @default.
• W2892271400 cites W2096874183 @default.
• W2892271400 cites W2112662877 @default.
• W2892271400 cites W2121690051 @default.
• W2892271400 cites W2126049444 @default.
• W2892271400 cites W2129281457 @default.
• W2892271400 cites W2134404484 @default.
• W2892271400 cites W2134634779 @default.
• W2892271400 cites W2147108549 @default.
• W2892271400 cites W2155984875 @default.
• W2892271400 cites W2158131645 @default.
• W2892271400 cites W2163756514 @default.
• W2892271400 cites W2164595809 @default.
• W2892271400 cites W2168581452 @default.
• W2892271400 cites W2170373471 @default.
• W2892271400 cites W2219591537 @default.
• W2892271400 cites W2298123402 @default.
• W2892271400 cites W2298338128 @default.
• W2892271400 cites W2529472149 @default.
• W2892271400 cites W2541013163 @default.
• W2892271400 cites W2551469077 @default.
• W2892271400 cites W2613818341 @default.
• W2892271400 cites W2739174192 @default.
• W2892271400 doi "https://doi.org/10.1136/bmj.k3426" @default.
• W2892271400 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6122252" @default.
• W2892271400 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30181258" @default.
• W2892271400 hasPublicationYear "2018" @default.
• W2892271400 type Work @default.
• W2892271400 sameAs 2892271400 @default.
• W2892271400 citedByCount "103" @default.
• W2892271400 countsByYear W28922714002018 @default.
• W2892271400 countsByYear W28922714002019 @default.
• W2892271400 countsByYear W28922714002020 @default.
• W2892271400 countsByYear W28922714002021 @default.
• W2892271400 countsByYear W28922714002022 @default.
• W2892271400 countsByYear W28922714002023 @default.
• W2892271400 crossrefType "journal-article" @default.
• W2892271400 hasAuthorship W2892271400A5006148147 @default.
• W2892271400 hasAuthorship W2892271400A5050587534 @default.
• W2892271400 hasAuthorship W2892271400A5067129696 @default.
• W2892271400 hasBestOaLocation W28922714001 @default.
• W2892271400 hasConcept C126322002 @default.
• W2892271400 hasConcept C142724271 @default.
• W2892271400 hasConcept C17923572 @default.
• W2892271400 hasConcept C197934379 @default.
• W2892271400 hasConcept C201903717 @default.
• W2892271400 hasConcept C204787440 @default.
• W2892271400 hasConcept C207103383 @default.
• W2892271400 hasConcept C2778115740 @default.
• W2892271400 hasConcept C2779826273 @default.
• W2892271400 hasConcept C2779944601 @default.
• W2892271400 hasConcept C2908647359 @default.
• W2892271400 hasConcept C42219234 @default.
• W2892271400 hasConcept C44249647 @default.
• W2892271400 hasConcept C71924100 @default.
• W2892271400 hasConcept C72563966 @default.
• W2892271400 hasConcept C98274493 @default.
• W2892271400 hasConcept C99454951 @default.
• W2892271400 hasConceptScore W2892271400C126322002 @default.
• W2892271400 hasConceptScore W2892271400C142724271 @default.
• W2892271400 hasConceptScore W2892271400C17923572 @default.
• W2892271400 hasConceptScore W2892271400C197934379 @default.
• W2892271400 hasConceptScore W2892271400C201903717 @default.
• W2892271400 hasConceptScore W2892271400C204787440 @default.
• W2892271400 hasConceptScore W2892271400C207103383 @default.
• W2892271400 hasConceptScore W2892271400C2778115740 @default.
• W2892271400 hasConceptScore W2892271400C2779826273 @default.
• W2892271400 hasConceptScore W2892271400C2779944601 @default.
• W2892271400 hasConceptScore W2892271400C2908647359 @default.
• W2892271400 hasConceptScore W2892271400C42219234 @default.
• W2892271400 hasConceptScore W2892271400C44249647 @default.

• next